3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
26
Lymphoma
22
Leukemia, Myeloid, Acute
21
Leukemia
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Non-Hodgkin
17
Myelodysplastic Syndromes
16
Hodgkin Disease
15
Leukemia, Lymphocytic, Chronic, B-Cell
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Hematologic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Follicular
6
Primary Myelofibrosis
5
Neoplasms, Plasma Cell
5
Myeloproliferative Disorders
5
Recurrence
4
Neuroblastoma
4
Graft vs Host Disease
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Polycythemia Vera
3
Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myelomonocytic, Juvenile
3
Ganglioneuroblastoma
3
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Rhabdomyosarcoma
2
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
Stem Cell Transplantation
×
Clear all
No trials found.